Twitter use in pharma: valuable or time sinkhole?

Posted 1st December 2009 in Articles, General | 9 comments

Image

Dr. Andree K Bates

Eularis

Current estimates say that Twitter, the microblogging marvel, has a total user count of around 8 million. Every day, up to 10,000 new people join. It’s no wonder that the New York Times calls Twitter “one of the fastest growing phenomena on the Internet.” The most recent figures from March of 2009 indicate Twitter has again nearly doubled, with 8 million unique visitors. Twitter users are primarily adults, and are highly mobile, updating through their laptops, Blackberries, iPhones and other devices. Together, users have created over billions of Tweets to date.

Twitter combines components of blogging, Facebook, and other social media and condenses it down to a small but potent task. Members post updates (called Tweets) of up to 140 characters as often as they wish. Ostensibly, the updates are to answer one question: “What are you doing?” Like Facebook and other networks, people can follow each other and their Tweets. Like many social media options, participants can reply to tweets, and begin a whole new conversation. The result is a constant stream of communication.

What’s all the buzz about? Is Twitter here to stay? Does it really provide business opportunity? Many Twitter naysayers contend that the whole exercise is pointless. Isn’t it a bit narcissistic and boring to keep everyone apprised of your lunch menu and what’s happening at work?

 

“Is Twitter here to stay? Does it really provide business opportunity?”

 

But those who support the tool and use it extensively proclaim its great power in communication. When it comes to the world of buying and selling, some major players stand by Twitter, and advocate interesting uses:

Dell has created a number of Twitter profiles, each focused on providing followers new deals. DellOutlet, for example, posts recent refurbished Dell computer offers.

Starbucks posts new offers and also participates in threaded discussions with their Twitter followers.

JetBlue answers questions and provides customer service through their Twitter account.

Southwest Airlines transfers the irreverent tone of their blog to Twitter, running non-official, entertaining discussions with their customers.

Whole Foods Market asks what their clients like to read and watch, recommends food media and podcasts, and invites them to store events.

HRBlock runs ask-and-answer sessions with their customers.

Forrester Research posts updates of their site’s new reports and recent discussions.

Kodak Chief Blogger posts the company blog updates, and invites discussions with customers and followers.

Zappos uses Twitter to connect on a personal level with their employees and customers. They highlight new deals, interesting facts, and share funny stories: Activity is not a sales driver, but a brand builder, driving repeat customers and word of mouth.

Twitter in healthcare and pharma

What about physicians? Physicians are an active user group of Twitter, and they’re working to push the boundaries of what to Tweet. Earlier this year, an oncological surgery at Henry Ford Hospital was broadcast to the Twitterverse, giving short, real-time updates on the procedure as a learning exercise in removing a kidney tumour without taking out the entire kidney. Doctors, medical students, and the simply curious around the world tuned in. This type of sharing will undoubtedly increase over time, especially as the medical student population grows increasingly fond of social networking and Twitter.

The patients are also using it. Twitter users are finding conversations about drug side effects, clinical trials, approvals, and recommendations infinitely easier and more useful through Twitter than many static sites. Countless twitter conversations on these topics have been documented and recorded.

So, the physicians and the patients are using it. What about pharma?

Pharma companies have been hesitant, worried about the unknown. This is probably largely driven by lack of knowledge about it as well as legal and regulatory fears. Nonetheless, some intrepid pharma companies have ventured into the unknown waters.

At the beginning of this year, several key pharma companies dove in to Twitter, setting up corporate accounts with a variety of content:

• Boehringer Ingelheim (@Boehringer) uses a point person, John Pugh, Boehringer’s director for global corporate communications/external communications, to personalise and participate. He posts press releases, links to Internet-based information about disease areas, and posts articles he thinks followers might find interesting.

• Johnson and Johnson (@JNJComm) have set up an account focused on personalising the company and building reputation. A real company member tweets and interacts with the public on a variety of topics.

• AstraZeneca (@AstraZenecaUS) is focusing on injecting information into the conversation, sending tweets on access programs, healthcare reform and strategy.

• Novartis (@Novartis) tweets from their corporate communications centre in Switzerland, and focuses on sending out their existing press releases.

These beginning moves are slow starts, but are providing an example for other pharma companies to watch and learn.

Opportunities

Ultimately, evangelists and pundits alike agree that companies, especially pharma, can use Twitter as a way to research, interact, assist customers proactively, build relationships, brand, understand more about the market, and learn from others in the field. It’s a way to open up dialogue, knock down the growing perception that pharma companies don’t care what their customers and peers think, and start to build trust. With these potential uses in mind, and taking a composite picture of what pharma, businesses, professionals, and everyday people have done with Twitter, companies can easily come up with a list of activities to try.

Before diving in, just as with any other new tactic, companies first need to think about strategy. Why do you want to use Twitter? What specifically are you looking to accomplish? Thinking about all the potential benefits and uses of Twitter, especially those listed above, what do you want to focus on? By far the most successful Twitter ventures are those that keep the role and needs of the customer in mind. People on Twitter, just like other social networks, don’t want to be sold or marketed to. Your goals should revolve around building relationships and providing value for customers.

 

“People on Twitter, just like other social networks, don’t want to be sold or marketed to.”

 

Another consideration is determining your corporate persona. Companies can opt to stick with the brand name, taking on a company personality that stays constant. Companies can also take it a step further, using and identifying specific employees. These individuals evangelise the brand, but also engage in personal interests and communication.

No matter how you decide to create a presence on Twitter, the necessary next step, and on ongoing step, is to listen. Follow the ebb and flow of conversation, and you can get a great feel for what content users like, what is important to users, and how you can fit in. Conduct searches on key topics, like your brand or your condition area, and you can get a highly concentrated and natural discussion from those on the ground.

With this planning as a foundation, how can you and your company use Twitter to build brands and boost sales?

Test new ideas: Want immediate feedback from the real world? Businesses are using Twitter as a place for thought balloons all the time, and receiving information that can help mould new products and services.

Publish news and info: One of the best parts of Twitter is its instantaneous reach. Take advantage of an interconnected network to blast your up-to-the-minute news on approvals, or send out missives on legislative acts under review.

Distribute promotions: Some of the biggest business presences on Twitter are revered for their sharing of coupons, deals, and other goodies with customers.

Create brand personality: Extend your social media and blogging strategy with Twitter, and you can more fully create the brand personality you’re striving to impart.

Engage in customer service: Offer your presence as a way for participants to get questions answered, get thoughts on specific products, and troubleshoot.

Keep them guessing: Include a wide variety of information in your Twitter stream, mixing information posts, links to other people’s posts, replies to questions, alerts, and more.

Remember that Twitter should be another way to add value for your followers and customers. Tweet when you find opportunities to do just that, rather than simply promoting your company and brands, and you can find great marketing benefit.

What to Tweet

To effectively create brand personality, engage followers and prospects, and build something unique, your presence should be constant and ever changing. Wondering what specifically to tweet about?

• Instead of answering the question, “What are you doing?”, answer the question, “What has your attention?”

• Ask questions. Twitter is great for getting opinions.

• Tweet about other people’s ideas, products and services. Great for developing networks and conversations.

• Give advice when you do mention your products.

• Share the human side of your company with pictures and personal posts.

• Mention events, both your own and others your audience might find interesting.

• Start contests: “The first three people who answer this trivia question get….”

• Reply to others (using @ and their twittername). The more personal the reply, the higher the impact.

• Point to your new blog posts, and promote other people’s blog posts that are of interest

• OH’s (overheard). These can be highly funny and personalising, along with fun Internet games and sites.

To really create value with your tweets, and to ensure content that’s continually engaging and attractive, keep consistency. Produce at least 10 tweets a week to maintain an active, current presence that people will trust. Also keep conversations to a group level. For private conversations stick to Direct Messages. This keeps clutter out of the main communication, but also prevents too much information being revealed. Always remember that Tweets are “on the record.” Everything you tweet is searchable on the Internet, aiding keyword searches, but also creating a public record of any missteps.

Follow those that follow you. Being connected in this way allows you to send direct messages when needed. This practice can also help prevent discomfort in the Twittersphere; if you proactively follow others without their initial interest, you run the risk of appearing like a spammer.

 

“Above all, prevent Twitter addiction. Twitter can easily turn into a time sink.”

 

Above all, prevent Twitter addiction. Twitter can easily turn into a time sink. Beginners especially can feel the need to read every single tweet, eating up hours of time that should be devoted elsewhere. To prevent addiction, many experienced participants invest preplanned blocks of time to catch up and converse. Filtering your Twitter traffic can also help; TweetDeck allows you set up groups and filter conversations for specific topics and specific people.

Twitter can be highly entertaining and highly effective way to build a brand, if you keep perspective. Twitter can resemble a cocktail party conversation in many ways, and stay limited to small talk and meaningless chit chat. But if you take it to the next level, with appropriate content and follow up, you can make it meaningful.

About the author:

For more information on this topic, please contact the author, Dr Andree Bates, at Eularis (www.eularis.com)

User Comments

petewest

1st December 2009, 13:25

petewest
I agree that Twitter is a valuable marketing tool that can be utilised by pharma. I am planning to use it to support our activities, for example at congress, in 2010.

I'd be interested to hear from others who may have already had experience of using this to support their pharma marketing strategies.
 

river

2nd December 2009, 10:55

river
No doublt, Twitter is a valuable market tool. But how to filter effect targeted group still is a big problem in my market (China). Because there are incalculability blogs from hundreds milliom user that alway dilute the voice from Twitter. Appracited if you can make comment on it.
 

klynn

2nd December 2009, 11:47

klynn
It's been a whole since we have conversed Andree! I agree with your points, but as you and I have both lived through the first boom and bust of Digital media for Pharma (back in 2000) I'm sensing a few similarities.

There is a lot of hype out there, (like last time) therefore any marketing strategy for social media should be an integrated "Closed Loop" marketing strategy that can link all channels together to garner deeper insights into their target audience groups be it HCPs or Patients.

The failures of yesteryear should be understood i.e. siloed echannel strategy, lack of positioning, listening and acting on hype.

The difference however, is this time round a number of us know the failure points so can now position more effectively digital media channels more appropriately. If I remember correctly when we did this back in 2000 the strategy was fine, but the majority of HCPs were not online and wouldn’t engage with Pharma online. I tknow there has been a significant change i.e. majority of HCPs are online and actively use it to help them in their works practices.

Also a strong consideration will be that local regulatory requirements will determine the uptake of Pharma using social media.

KR

Klynn

p.s. And this just in from the BBC:
Doctors warned about risk of 'Facebook flirts'
http://news.bbc.co.uk/1/hi/health/8389458.stm
 

bobstewart

2nd December 2009, 22:55

bobstewart
With INTERPHEX we've begun to actively build our Twitter following as part of an overall marketing, communications, and social media strategy. We're using TweetDeck as our platform where we've built specific groups to filter the often chaotic Twitter stream. TweetDeck also allows you to link to Facebook and you will soon be able to do the same with LinkedIn so TweetDeck can serve as an overall platform for social media's "Big Three".

Presently, our main Twitter use is as a quasi-newsfeed monitoring the conversation and developments in the Pharma market, making some comments, and occasionally retweeting interesting tweets and articles. As INTERPHEX approaches we will establish an event #hashtag and start to engage in conversation about the event itself, use Twitter for customer service, and attempt to establish a following who will use Twitter during the actual event.

We don't have any major preconceived notions as to how well Twitter will work. Our major assumption is that social media is transforming how we interact and you need to at least be on the playing field to engage in the conversation, make some mistake, and ultimately determine how to best use this new suite of tools and communication channels.

Bob Stewart
 

jonmrich

4th December 2009, 19:23

jonmrich
Those four pharma companies you have listed are just the beginning. Here's a list of about 15 more: http://bit.ly/657dMD

Jonathan
http://www.doseofdigital.com
 

wordwritepr

7th December 2009, 18:44

wordwritepr
Great post! This is very helpful for companies to gauge what is happening on Twitter in the world of pharma. Thanks also to Jonathan who posted the above link to the Healthcare and social media wiki. We have a healthcare Twitter page so these sources are going to come in handy when looking to broaden our reach.

Deanna from WordWrite Communications (http://twitter.com/healthcarebuzz)
 

SeanJohnson

7th April 2010, 20:42

SeanJohnson
A little late to the discussion, but perhaps it's time for an update in this area? It seems like pharma companies have come to the conclusion that it's necessary for them to be using this social media outlet, but are waiting on direction from the FDA (which obviously began at the hearings this past winter). Jon's Dose of Digital blog does a nice job keeping up with this, but I'd like to know what others think about what the next steps will be in terms of rules or regulations being enforced on Twitter.

Sean Johnson, www.avatarnewsletter.com
 

andrewspong

22nd April 2010, 09:35

andrewspong
@Sean - I have no crystal ball to scry into, but I'd say it's extremely unlikely that the FDA is going to offer specific guidance regarding pharma's use of social media.

From a European perspective, both the PMCPA and EFPIA stated explicitly at recent conferences that (in the case of the former) there is nothing in clause 32-34 of the current ABPI code that stops pharma doing anything within the social web that they would consider doing within any other promotional channel, and (in the case of the latter) that EU regulation is always going to be behind the curve in this regard on the basis that it takes 3 years to get a piece of legislation passed.

Who has heard of Twitter 3 years ago? What will the social web look like in 3 years time as we transition from dictated to participatory medicine and the inexorable rise of the epatient continues?

In the interim, the message coming out of the professional congresses that have taken place this year thus far from the regulators have been: talk to us; there's nothing your're currently doing elsewhere that you couldn't do within the social web; we can't adjust our existing regulations until you've tested their boundaries; keep listening, keep learning, but start acting.

The AER bugbear has been exploded as a myth (<1 in 500 reportable events - although that doesn't mean you don't need a social media governance policy and a clear escalation strategy when things do go wrong), and most of the other excuses that pharma trots out look like smoke and mirrors masking the real reason pharma is dragging its feet, which are mostly organizational (in terms of thinking and action).

I say more about this here: http://stwem.com/2010/04/07/what-pharma-doesnt-need-better-ways-to-say-no/

There are many other directions we could take this conversation in, but I can't sign off without asking 'how are we measuring the success of those vanguard pharma accounts that *have* taken the plunge?' I make the case here that the traditional 'ranking by "Follower"' measure is not all that useful, and propose new metrics to assess achievement (as well as asking what constitutes that achievement):

http://stwem.com/2010/04/15/top-20-pharma-accounts-issue-1-2010/
 

llamafama

30th August 2010, 16:30

llamafama
It would be interesting to find out how the pattern of Twitter usage by pharma companies has changed over the past year and which, if any, tweets have been relatively successful. Personally, I think perhaps the best mode of interaction for pharmaceutical companies with physicians is to tweet about their latest research, abstracts and posters at conferences, and other educational activities, as it could otherwise be construed as too promotional.

The thing about twitter is that it is supposed to be laid-back, informal and entertaining, which are not things that pharma companies typically feel comfortable doing.
 

Post Comment

Comments are moderated, and will not appear until approved by a member of the pharmaphorum team.

You must be logged in to post a comment.